Literature DB >> 426477

Effects of bicuculline-induced seizures on cerebral metabolism and circulation of rats rendered hypoglycemic by starvation.

G Blennow, J Folbergrová, B Nilsson, B K Siesjö.   

Abstract

To evaluate the effects of substrate deficiency on cerebral function, metabolism, and blood flow during seizures, rats were injected intravenously with bicuculline (1.2 mg.kg-1) following a 24-hour period of starvation. During the course of seizures, blood glucose concentrations fell, and when they were reduced to below about 3 mumol.gm-1, cerebral function, metabolism, and blood flow altered. Changes in function involved the transition of an electroencephalographic pattern of bursts and suppression into one of frequent or sparse single spikes. Oxygen consumption, which initially increased at least twofold, fell toward normal or subnormal values in the single-spike period. Cortical blood flow was markedly reduced, and there was an attenuated response to carbon dioxide administration. Simultaneously, a small but clear fall was detected in the cerebral phosphorylation potential, and concentrations of glycolytic metabolites (including lactate) and citric acid cycle intermediates were reduced. Changes in amino acids and ammonia were somewhat similar to those observed in insulin-induced hypoglycemia, but since the amino acid pool did not fall, the experiments failed to give evidence that amino acids serve as oxidative substrates. The perturbation of cerebral energy state (and of levels of carbohydrate substrates and amino acids) was reversed by glucose administration; but since neither this procedure nor additional bicuculline injections could cause resumption of continuous seizure activity, the results suggest that cellular substrate depletion may have given rise to a sustained disturbance of synaptic transmission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426477     DOI: 10.1002/ana.410050207

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine.

Authors:  N Y Walton; A K Nagy; D M Treiman
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

2.  GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus.

Authors:  C G Wasterlain; C F Baxter; R A Baldwin
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

3.  Glucose sparing by glycogenolysis (GSG) determines the relationship between brain metabolism and neurotransmission.

Authors:  Douglas L Rothman; Gerald A Dienel; Kevin L Behar; Fahmeed Hyder; Mauro DiNuzzo; Federico Giove; Silvia Mangia
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-07       Impact factor: 6.960

4.  Regional changes in transmitter amino acids during focal and generalized seizures in rats.

Authors:  A G Chapman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  Pathogenesis of brain lesions caused by experimental epilepsy. Light- and electron-microscopic changes in the rat cerebral cortex following bicuculline-induced status epilepticus.

Authors:  B Söderfeldt; H Kalimo; Y Olsson; B Siesjö
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

6.  Changes in brain blood flow associated with deltamethrin-induced choreoathetosis in the rat.

Authors:  D E Ray
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

7.  Insulin increases glucose transfer across the blood-brain barrier in man.

Authors:  M M Hertz; O B Paulson; D I Barry; J S Christiansen; P A Svendsen
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 8.  Bedside interpretation of cerebral energy metabolism utilizing microdialysis in neurosurgical and general intensive care.

Authors:  Carl-Henrik Nordström; Axel Forsse; Rasmus Peter Jakobsen; Simon Mölström; Troels Halfeldt Nielsen; Palle Toft; Urban Ungerstedt
Journal:  Front Neurol       Date:  2022-08-10       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.